ETF Holdings Breakdown of EXAS

EXAS institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-29	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	129,515	USD 6,913,511
2025-09-29	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	84,384	USD 4,504,418
2025-09-29	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	230,974	USD 12,329,392
2025-09-29	IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF)	227	USD 12,117 -0.4%
2025-09-29	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	4,687	USD 250,192 -0.4%
2025-09-29	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	981	USD 52,366 -0.4%
Total =		450,768	USD 24,061,996

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with EXAS

Exact Sciences Corporation (NASDAQ:EXAS) Receives $68.05 Average Target Price from Analysts

Exact Sciences Corporation (NASDAQ:EXAS – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-four analysts that are presently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation, nineteen have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-09-18 02:44:51

Exact Sciences Corporation (NASDAQ:EXAS) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Exact Sciences Corporation (NASDAQ:EXAS – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, twenty have issued a buy recommendation and one has given a strong buy recommendation to […] - 2025-08-21 02:22:53

Maryland State Retirement & Pension System Sells 1,948 Shares of Exact Sciences Corporation (NASDAQ:EXAS)

Maryland State Retirement & Pension System trimmed its holdings in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 18.6% during the first quarter, Holdings Channel reports. The institutional investor owned 8,526 shares of the medical research company’s stock after selling 1,948 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Exact Sciences […] - 2025-08-17 05:17:01

BTIG Research Has Lowered Expectations for Exact Sciences (NASDAQ:EXAS) Stock Price

Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target dropped by analysts at BTIG Research from $65.00 to $60.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. BTIG Research’s price target points to a potential upside of 33.60% from the company’s […] - 2025-08-14 04:31:00

Exact Sciences Corporation (NASDAQ:EXAS) Shares Sold by Deutsche Bank AG

Deutsche Bank AG lessened its stake in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 47.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 944,021 shares of the medical research company’s stock after selling 856,191 shares during the period. Deutsche […] - 2025-08-13 07:04:51

Exact Sciences (NASDAQ:EXAS) Stock Rating Upgraded by Wall Street Zen

Exact Sciences (NASDAQ:EXAS – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday. Other research analysts also recently issued research reports about the company. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $46.00 […] - 2025-08-11 05:44:53

Larson Financial Group LLC Purchases 589 Shares of Exact Sciences Corporation (NASDAQ:EXAS)

Larson Financial Group LLC raised its position in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 2,804.8% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 610 shares of the medical research company’s stock after buying an additional 589 shares during the period. Larson Financial Group LLC’s […] - 2025-07-23 05:53:06

Cerity Partners LLC Grows Position in Exact Sciences Corporation (NASDAQ:EXAS)

Cerity Partners LLC raised its stake in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 24.0% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 33,598 shares of the medical research company’s stock after buying an additional 6,508 shares during the period. Cerity Partners LLC’s holdings in Exact Sciences were worth $1,454,000 at […] - 2025-07-22 10:16:51

Cwm LLC Acquires 6,217 Shares of Exact Sciences Corporation (NASDAQ:EXAS)

Cwm LLC increased its holdings in shares of Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 41.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 21,316 shares of the medical research company’s stock after purchasing an additional 6,217 shares […] - 2025-07-22 09:24:49

Cerity Partners LLC Has $1.45 Million Stock Position in Exact Sciences Corporation (NASDAQ:EXAS)

Cerity Partners LLC increased its position in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 24.0% in the 1st quarter, Holdings Channel reports. The firm owned 33,598 shares of the medical research company’s stock after buying an additional 6,508 shares during the quarter. Cerity Partners LLC’s holdings in Exact Sciences were worth $1,454,000 as of […] - 2025-07-22 07:49:01

Envestnet Asset Management Inc. Sells 8,891 Shares of Exact Sciences Corporation (NASDAQ:EXAS)

Envestnet Asset Management Inc. cut its stake in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 3.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 246,353 shares of the medical research company’s stock after selling 8,891 shares during the quarter. Envestnet Asset Management […] - 2025-07-21 04:30:52

Xponance Inc. Acquires 959 Shares of Exact Sciences Corporation (NASDAQ:EXAS)

Xponance Inc. grew its holdings in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 4.0% in the 1st quarter, HoldingsChannel reports. The firm owned 24,972 shares of the medical research company’s stock after buying an additional 959 shares during the quarter. Xponance Inc.’s holdings in Exact Sciences were worth $1,081,000 as of its most recent […] - 2025-07-16 05:56:52

Exact Sciences Corporation (NASDAQ:EXAS) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. lessened its stake in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 4.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 773,975 shares of the medical research company’s stock after selling 34,540 shares during the quarter. Principal Financial […] - 2025-07-08 06:45:04

KBC Group NV Sells 200,000 Shares of Exact Sciences Corporation (NASDAQ:EXAS)

KBC Group NV lowered its holdings in shares of Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 87.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,742 shares of the medical research company’s stock after selling 200,000 shares during the quarter. […] - 2025-07-04 05:22:53

Exact Sciences Corporation (NASDAQ:EXAS) Stock Position Cut by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lessened its stake in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 39.9% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 567,506 shares of the medical research company’s stock after selling 377,455 shares during the period. Sumitomo Mitsui […] - 2025-07-03 05:35:00

Exact Sciences Corporation (NASDAQ:EXAS) Given Average Rating of “Moderate Buy” by Analysts

Exact Sciences Corporation (NASDAQ:EXAS – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-two brokerages that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to […] - 2025-07-02 02:42:46

Robeco Institutional Asset Management B.V. Increases Stock Position in Exact Sciences Corporation (NASDAQ:EXAS)

Robeco Institutional Asset Management B.V. raised its holdings in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 298.6% during the first quarter, Holdings Channel.com reports. The firm owned 148,629 shares of the medical research company’s stock after purchasing an additional 111,343 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Exact Sciences were […] - 2025-06-30 06:10:48

QRG Capital Management Inc. Has $1.89 Million Stake in Exact Sciences Corporation (NASDAQ:EXAS)

QRG Capital Management Inc. grew its holdings in Exact Sciences Corporation (NASDAQ:EXAS – Free Report) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 43,589 shares of the medical research company’s stock after purchasing an additional 1,128 shares during the […] - 2025-06-20 05:36:52

XBI, EXAS, NBIX, NTRA: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37

Park Avenue Securities LLC Boosts Stake in Exact Sciences Co. (NASDAQ:EXAS)

Park Avenue Securities LLC grew its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.1% during the first quarter, Holdings Channel reports. The fund owned 25,335 shares of the medical research company’s stock after purchasing an additional 1,449 shares during the period. Park Avenue Securities LLC’s holdings in Exact Sciences were […] - 2025-06-13 04:46:48

Merit Financial Group LLC Has $381,000 Stake in Exact Sciences Co. (NASDAQ:EXAS)

Merit Financial Group LLC lifted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 110.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,799 shares of the medical research company’s stock after buying an additional 4,609 shares […] - 2025-06-12 05:32:53

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Gateway Investment Advisers LLC

Gateway Investment Advisers LLC trimmed its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 14.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,612 shares of the medical research company’s stock after selling 918 shares during the quarter. Gateway Investment Advisers […] - 2025-06-10 05:58:43

Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Rhumbline Advisers

Rhumbline Advisers lifted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1.8% during the first quarter, Holdings Channel.com reports. The firm owned 221,301 shares of the medical research company’s stock after acquiring an additional 3,873 shares during the period. Rhumbline Advisers’ holdings in Exact Sciences were worth $9,580,000 as of […] - 2025-06-10 04:56:50

Wealth Enhancement Advisory Services LLC Purchases 3,434 Shares of Exact Sciences Co. (NASDAQ:EXAS)

Wealth Enhancement Advisory Services LLC lifted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 39,135 shares of the medical research company’s stock after acquiring an additional 3,434 shares […] - 2025-06-06 05:29:03

Notable ETF Outflow Detected - XBI, EXAS, NBIX, NTRA

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $257.5 million dollar outflow -- that's a 5.2% decrease week over week - 2025-05-30 14:40:38

XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $288.7 million dollar outflow -- that's a 5.9% decrease week over week - 2025-05-09 11:52:51

Exact Sciences (NASDAQ:EXAS) Stock Price Up 3.6% Following Analyst Upgrade

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was up 3.6% on Monday after Barclays raised their price target on the stock from $55.00 to $75.00. Barclays currently has an overweight rating on the stock. Exact Sciences traded as high as $53.87 and last traded at $53.43. Approximately 587,969 shares changed hands during mid-day trading, […] - 2025-05-06 02:10:58

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by NewEdge Advisors LLC

NewEdge Advisors LLC lessened its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 66.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,989 shares of the medical research company’s stock after selling 7,911 shares during the quarter. NewEdge […] - 2025-05-02 05:19:03

Guggenheim Capital LLC Decreases Stock Position in Exact Sciences Co. (NASDAQ:EXAS)

Guggenheim Capital LLC reduced its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 28,797 shares of the medical research company’s stock after selling 4,459 shares during the period. Guggenheim Capital LLC’s holdings in Exact Sciences were worth $1,618,000 at the end […] - 2025-04-21 05:14:52

Brokerages Set Exact Sciences Co. (NASDAQ:EXAS) Price Target at $69.25

Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twenty-two analysts that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong […] - 2025-04-21 02:46:53

Back to Listing

Disclaimer